Abbott Laboratories Stock Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Wiener Boerse
09/10/2026
|
5-day change | 1st Jan Change | ||
| 88.96 EUR | +2.28% |
|
+3.39% | -16.04% |
| 10-09 | Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase | MT |
| 10-07 | Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder | CI |
| Market Cap | 172B 154B 143B 130B 246B 16,671B 247B 1,722B 674B 8,490B 647B 633B 27,273B | P/E 2026 * |
29.2x | P/E 2027 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 196B 175B 163B 148B 280B 18,987B 281B 1,962B 767B 9,669B 737B 721B 31,061B | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 3.54x |
| Free-Float |
86.16% | Yield 2026 * |
2.58% | Yield 2027 * | 2.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Xetra
| ABL | Delayed | |
|
London S.E.
| ABT | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +2.28% | ||
| 1 week | +3.39% | ||
| Current month | +0.88% | ||
| 1 month | -2.78% | ||
| 3 months | +7.93% | ||
| 6 months | +1.67% | ||
| Current year | -16.04% |
| 1 week | 86.98 |  | 89.54 |
| 1 month | 85.96 | | 91.26 |
| Current year | 70.1 | | 109.64 |
| 1 year | 70.1 | | 115.8 |
| 3 years | 70.1 | | 134.2 |
| 5 years | 70.1 | | 134.2 |
| 10 years | 49.6 | | 134.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.28% | +3.39% | - | - | 172B | |
| +1.13% | +2.15% | -25.29% | +2.94% | 172B | |
| +0.83% | +2.43% | -8.31% | +17.77% | 113B | |
| +0.13% | +0.69% | -25.09% | +3.95% | 106B | |
| +2.34% | +2.49% | -47.36% | -10.38% | 75.31B | |
| +0.78% | +4.79% | +3.10% | +73.94% | 61.8B | |
| +0.12% | +3.62% | +12.66% | +67.70% | 52.93B | |
| +0.55% | +3.93% | -2.82% | -30.87% | 50.05B | |
| +0.95% | -0.08% | -17.61% | +17.13% | 40.81B | |
| -0.36% | -1.46% | +23.55% | +1.23% | 31.74B | |
| Average | +0.88% | +1.94% | -9.69% | +15.93% | 78.28B | |
| Weighted average by Cap. | +1.12% | +2.09% | -15.31% | +13.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.2B 44.82B 41.67B 37.94B 71.56B 4,856B 71.9B 502B 196B 2,473B 189B 184B 7,944B | 54.53B 48.68B 45.26B 41.22B 77.73B 5,275B 78.1B 545B 213B 2,686B 205B 200B 8,629B |
| Net income | 6.21B 5.55B 5.16B 4.7B 8.85B 601B 8.9B 62.09B 24.28B 306B 23.33B 22.82B 983B | 7.89B 7.05B 6.55B 5.97B 11.25B 764B 11.31B 78.89B 30.85B 389B 29.64B 28.99B 1,249B |
| Net Debt | 23.94B 21.37B 19.87B 18.09B 34.12B 2,316B 34.29B 239B 93.57B 1,179B 89.89B 87.92B 3,788B | 20.96B 18.71B 17.39B 15.84B 29.87B 2,027B 30.02B 209B 81.92B 1,032B 78.69B 76.97B 3,316B |
| Date | Price | Change |
|---|---|---|
| 09/10/26 | €88.96 | +2.28% |
| 08/10/26 | €86.98 | -0.80% |
| 07/10/26 | €87.68 | -0.57% |
| 06/10/26 | €88.18 | -1.19% |
| 05/10/26 | €89.24 | +3.72% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
